Bnp Paribas Biogen Inc. Transaction History
Bnp Paribas
- $2.41 Trillion
- Q3 2024
A detailed history of Bnp Paribas transactions in Biogen Inc. stock. As of the latest transaction made, Bnp Paribas holds 700 shares of BIIB stock, worth $105,917. This represents 0.01% of its overall portfolio holdings.
Number of Shares
700
Previous 700
-0.0%
Holding current value
$105,917
Previous $162 Million
16.18%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,037Shares Held
126MCall Options Held
1.13MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.52 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.47 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.2 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.11 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$795 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.8B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...